Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 34 min ago
Peer-reviewedLicence not statedBiochemical pharmacology

Pharmacological Antagonism of HTR2B Reduces ERK and STAT3 Activation and Prevents Renal Fibrosis During the Development of Adenine-Induced CKD in Rats

  • Kai W. McAlister1,2
  • Natalie E. Scholpa1,3
  • Jaroslav Janda1
  • Rick G. Schnellmann1,2,3
  1. 1Department of Pharmacology & Toxicology, University of Arizona, Tucson, Arizona, USA
  2. 2Southwest Environmental Health Science Center, University of Arizona, Tucson, Arizona, USA
  3. 3Southern Arizona VA Health Care System, Tucson, Arizona, USA
Read full textDOICite

Related

  1. Pharmacological activation of mitophagy prevents calcific aortic valve disease by targeting dysregulated mitochondrial-to-nuclear communication
    D. Zhou, H. Dai, J. Qiu +21
    bioRxivPreprintCC BY-NC-NDFull textGeneral medicinebioRxiv
  2. An ibuprofen-eluting electrospun membrane prevents ureteral fibrosis by dampening macrophage-associated fibroblast activation
    Xi Zhang, Da Zhong, Zihao Xu +8
    Materials Today BioPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsDOAJEurope PMC
  3. Targeting the Kidneys Osmotic Gradient with AVPR2 Antagonism Limits Inflammation and Fibrosis after Injury
    K. I. Lopez-Cayuqueo, F. J. Boivin, S. Cao +5
    bioRxivPreprintAll rights reservedFull textGeneral medicinebioRxiv
  4. Pharmacological targeting of bunyavirus-induced synaptic impairment prevents neuronal hyperexcitability
    Barbara Gorda, Jules Bouget, Vaishali Saini +15
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textInfectious diseaseHAL
  5. A Long-Acting Farnesoid X Receptor (FXR) Agonist Prevents Fibrosis
    Ashrafi Sultana, Grace Bybee, Anup S. Pathania +11
    BiomoleculesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC

Cite

BibTeXRIS
BibTeX
@article{mcalister2026pharmacological,
  title = {{Pharmacological Antagonism of HTR2B Reduces ERK and STAT3 Activation and Prevents Renal Fibrosis During the Development of Adenine-Induced CKD in Rats}},
  author = {Kai W. McAlister and Natalie E. Scholpa and Jaroslav Janda and Rick G. Schnellmann},
  journal = {Biochemical pharmacology},
  year = {2026},
  month = sep,
  doi = {10.1016/j.bcp.2026.118482},
  url = {https://doi.org/10.1016/j.bcp.2026.118482},
}
RIS
TY  - JOUR
TI  - Pharmacological Antagonism of HTR2B Reduces ERK and STAT3 Activation and Prevents Renal Fibrosis During the Development of Adenine-Induced CKD in Rats
AU  - Kai W. McAlister
AU  - Natalie E. Scholpa
AU  - Jaroslav Janda
AU  - Rick G. Schnellmann
PY  - 2026
DA  - 2026/09/16
JO  - Biochemical pharmacology
DO  - 10.1016/j.bcp.2026.118482
UR  - https://doi.org/10.1016/j.bcp.2026.118482
SN  - 0006-2952
SN  - 1873-2968
ER  -